2 Patienter bør nøje monitoreres for at sikre, at den lavest godkendte dosis MIRCERA anvendes til at sørge for tilstrækkelig kontrol af de anæmiske symptomer.
2 Patients should be monitored closely to ensure that the lowest approved dose of MIRCERA is used to provide adequate control of the symptoms of anaemia.